Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126350181 | 12635018 | 1 | I | 20160727 | 20160808 | 20160808 | PER | US-ASTRAZENECA-2016SE81870 | ASTRAZENECA | 0.00 | F | Y | 86.20000 | KG | 20160808 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126350181 | 12635018 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 250 MCG / 1.2 ML PEN, TWICE A DAY | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||||
| 126350181 | 12635018 | 2 | SS | LISINOPRIL HCTZ | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Oral | 10-12.5 MG , DAILY | 0 | TABLET | |||||||||
| 126350181 | 12635018 | 3 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 0 | 4 | MG | ||||||||||
| 126350181 | 12635018 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | 300 | MG | QD | |||||||||
| 126350181 | 12635018 | 5 | C | REPAGLINIDE. | REPAGLINIDE | 1 | 0 | 2 | MG | ||||||||||
| 126350181 | 12635018 | 6 | C | ZOCOR | SIMVASTATIN | 1 | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126350181 | 12635018 | 1 | Diabetes mellitus |
| 126350181 | 12635018 | 2 | Blood pressure measurement |
| 126350181 | 12635018 | 3 | Diabetes mellitus |
| 126350181 | 12635018 | 4 | Neuropathy peripheral |
| 126350181 | 12635018 | 5 | Diabetes mellitus |
| 126350181 | 12635018 | 6 | Diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126350181 | 12635018 | Blood glucose increased | |
| 126350181 | 12635018 | Drug dose omission | |
| 126350181 | 12635018 | Product quality issue | |
| 126350181 | 12635018 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |